Deepak L. Bhatt, MD, MPH: Let me turn now to Dr Navar to discuss what I think is an important part of the discussion. She’s done a lot of work on this. How do we actually estimate patients’ risk for ...

The field of retinal imaging has long provided a unique, non-invasive window to systemic vascular health, with microvascular ...

Read this article to learn how to conduct an advanced cardiovascular assessment to reveal heart abnormalities and associated symptoms and risk factors. Cardiovascular disease remains one of the ...

CMS released proposals to update cardiovascular disease risk assessment and risk management services. The organization proposed coding and payment for an atherosclerotic cardiovascular disease risk ...

Please provide your email address to receive an email when new articles are posted on . Peripheral artery disease, or PAD, is a leading cause of lower extremity amputations in the U.S. Health care use ...

Please provide your email address to receive an email when new articles are posted on . Cardiovascular risk-screening and stratification is advised for IBD patients before JAK inhibitor or S1P ...

Chronic kidney disease (CKD) is a strong cardiovascular risk factor and is often accompanied by hypertension and diabetes. Despite the disease's prevalence - 10 percent of individuals across the globe ...

The effect of Invokana on CV risk was evaluated in the CANVAS (CANagliflozin cardioVascular Assessment Study) Program in >10,000 adults with T2D who had established CV disease or were at risk for CV ...

Sometimes, a study on one topic can reveal important issues in another. Case in point: A recent Lancet study explored what a person’s life was like before they developed chronic pain — the diseases ...

Steatotic liver disease (commonly called fatty liver disease) progresses silently. Even in the absence of noticeable symptoms ...